Previous Article | Next Article ![]()
Journal of Clinical Microbiology, December 1998, p. 3463-3467, Vol. 36, No. 12
Veterinary and Agrochemic Research Center
(CODA/CERVA), B-1180 Ukkel, Belgium
Received 20 May 1998/Returned for modification 30 June
1998/Accepted 1 September 1998
The objective of the present study was to gain a better
understanding of the epidemiology of encephalomyocarditis virus (EMCV) infections in pigs by applying molecular techniques. The diagnostic potential of a reverse transcription-PCR (RT-PCR) targeting 286 nucleotides at the 3' end of the gene which encodes the viral polymerase was assessed with experimental and field samples. In addition, the use of the amplified sequences for an epidemiological study was evaluated. The heart was clearly shown to be the most suitable organ. The detection limit was determined to be 1 viral particle in 100 mg of heart tissue. The sensitivity and specificity of
the assay on the basis of the results obtained in this study were 94 and 100%, respectively. Phylogenetic analysis of the amplified sequences classified EMCVs in two distinct lineages. Group A consists of the reference strain ATCC 129B, all isolates collected between 1991 and 1994 in Belgium in association with reproductive failure, and all
Greek isolates. All Belgian isolates collected since the first
isolation of EMCV in relation to myocardial failure in fatteners in
Belgium group together with the isolates from Cyprus (1996 and 1997),
Italy (1986 to 1996), and France (1995) in group B irrespective of
their pathogenicity. The analyzed part of the 3D gene differed by
13.0% between Groups A and B. In contrast to the sequence homogeneity
of the Belgian isolates collected between 1991 and 1994, molecular
diversity, which ranged between 0 and 2%, was observed among the
Belgian isolates collected in 1995 and 1996. Among all Greek isolates
the diversity ranged between 1 and 8%. However, this diversity does
not seem to reflect geographical links between the outbreaks. A RT-PCR
for the rapid and specific diagnosis of EMCV in a variety of clinical
samples followed by nucleotide sequence analysis proved to be valuable
for molecular epidemiological studies.
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Identification of Encephalomyocarditis Virus in
Clinical Samples by Reverse Transcription-PCR Followed by Genetic
Typing Using Sequence Analysis
*
Corresponding author. Mailing address: Veterinary and
Agrochemic Research Center (CODA/CERVA), Groeselenberg 99, B-1180
Ukkel, Belgium. Phone: 32 (0)2 375 44 55. Fax: 32 (0)2 375 09 79. E-mail: frank.koenen{at}var.fgov.be.
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|